Other variants, even those in known genes, took substantial effort and resources to validate such as a p.(His457fs) in FOXN1 which revealed a novel dominant negative disease mechanism [130, 131], and confirmation of the effect of SEC23B variants which required detailed electron micrographs to differentiate between diagnoses of hereditary spherocytosis or CDAII. This evidence concerns the gene SEC23B and hereditary spherocytosis.